ResearcherColumbia UniversityActive in the last 2 years
Raúl Rabadán
Matched on ORCID iD 0000-0001-7946-9255; OpenAlex author ID A5056128255. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 3, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 6
- Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. First author DOI 10.1038/s41467-026-69055-2↗
- Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. First author DOI 10.1038/s41467-025-65811-y↗
- HLA-A*02:01allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of theHLAvariation in PDAC First author DOI 10.1101/2024.08.29.24312704↗
- Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2023.12.24.573257↗
- Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2022.2066767↗
- Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Last author DOI 10.1136/gutjnl-2017-314353↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gulam Abbas Manji · 2 shared papers, 2022–2023 · strength 0.28
- H. Carlo Maurer · 2 shared papers, 2019–2023 · strength 0.25
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257↗
- Paper Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarc… DOI 10.1136/gutjnl-2017-314353↗
- Kenneth P. Olive · 2 shared papers, 2019–2023 · strength 0.25
- Paper Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of p… DOI 10.1101/2023.12.24.573257↗
- Paper Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarc… DOI 10.1136/gutjnl-2017-314353↗
- Alina Cornelia Iuga · 1 shared paper, 2023 · strength 0.17
- Michael S. May · 1 shared paper, 2023 · strength 0.17
- Alexander Grenander Raufi · 1 shared paper, 2023 · strength 0.17
- Emily Linda Alouani · 1 shared paper, 2023 · strength 0.17
- Alberto Langtry · 1 shared paper, 2024 · strength 0.14
- Evangelina López de Maturana · 1 shared paper, 2024 · strength 0.14
- Linda Sharp · 1 shared paper, 2024 · strength 0.14
- Rafael Álvarez-Gallego · 1 shared paper, 2024 · strength 0.14
- Florian Castet · 1 shared paper, 2024 · strength 0.14
- Luis Muñoz‐Bellvís · 1 shared paper, 2024 · strength 0.14
- Rita Teresa Lawlor · 1 shared paper, 2024 · strength 0.14
- Gaby J. Strijk · 1 shared paper, 2024 · strength 0.14
- Núria Malats · 1 shared paper, 2024 · strength 0.14
- J. Enrique Domínguez‐Muñoz · 1 shared paper, 2024 · strength 0.14
- Alfredo Carrato · 1 shared paper, 2024 · strength 0.14
- William Greenhalf · 1 shared paper, 2024 · strength 0.14
- Christoph W. Michalski · 1 shared paper, 2024 · strength 0.14
- Jorg H. Kleeff · 1 shared paper, 2024 · strength 0.14
- Casper H.J. van Eijck · 1 shared paper, 2024 · strength 0.14
- Bo Kong · 1 shared paper, 2024 · strength 0.14
- Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2024 · strength 0.14
- Thomas Mathias Gress · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.